Mettler-Toledo International Inc. — Cyborg Score 8/10

Strategic Profile

Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 28%, China about 16% and the rest of the world about 19%. Mettler-Toledo combines market leadership in core products with recurring service revenue and strategic acquisitions.

Cyborg Score Rationale

The company has a current market capitalization of $27.7B with strong profitability. Quarterly revenue was up 8.1% on a year-over-year basis demonstrating solid organic growth. The company maintains market dominance with high margins and cash generation despite some near-term margin compression.

Top Insights

• Dominates lab balance market with 50%+ share, providing significant competitive moat
• Quarterly revenue growing 8.1% YoY with broad-based geographic and product growth
• EPS grew at 10.8% compounded annual growth rate over five years, outpacing 5.5% revenue growth through financial engineering and share buybacks
• FY 2026 EPS guidance at $46.05-$46.70 suggests continued earnings momentum

Named Competitors

• Agilent Technologies — Life sciences and diagnostics instrumentation
• IQVIA Holdings — Pharmaceutical and clinical research services
• Charles River Laboratories — Drug development and safety assessment services
• Revvity — Life sciences analytical instrumentation

Recent Developments

• (February 2026) Quarterly revenue beats analyst expectations with 8.1% YoY growth
• (November 2025) Q4 2025 adjusted EPS of $13.36 beats estimates; FY 2026 guidance provided
• (November 2023) Acquired Acme Scale to expand industrial weighing capabilities

Open the full interactive Mettler-Toledo International Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.